Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Rapid diagnosis of pulmonary tuberculosis by an enzyme-linked immunospot assay using induced sputum cells Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Source: Eur Respir J 2008; 32: 1607-1615 Year: 2008
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Significance of interferon gamma-inducible chemokines in pleural effusions Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Evaluation of cut-off values of QuantiFERON-TB Gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012
Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection Source: Eur Respir J 2013; 41: 644-648 Year: 2013